- 05:51 PM In good spirits: Beam Global bets big on India
- 05:47 PM Trellisys.net: Cashing in on the social networking...
- 05:34 PM Obama asks Americans for patience on economy
- 05:34 PM Italy arrests Pakistanis suspected of Mumbai links
- 04:37 PM Govt plans rice reserve sale in local markets
- 04:22 PM Aurobindo Pharma sees $2 bn sales in next 3 ye...
- 04:07 PM Now, Daigeo's duty free products are under DRI len...
- 03:11 PM RBI's new forex derivative rule too liberal, say e...
- 02:30 PM Implications of tax treaty re-negotiation
- 02:25 PM Beware unearths how agents allegedly sell cars at ...
.jpg)
Dr Reddys Laboratories has announced its second quarter results. The company's Q2 consolidated net profit was up 107% at Rs 217.3 crore versus Rs 105.3 crore. (As Per IFRS).
Key Takeaways from Dr Reddys Laboratories cocall:
|
Also Read
RSS feed for news |
Dr Reddys Laboratories has announced its second quarter results. The company's Q2 consolidated net profit was up 107% at Rs 217.3 crore versus Rs 105.3 crore. (As Per IFRS).
Its consolidated net sales were up 14% at Rs 1836.8 crore versus Rs 1615.1 crore. (As Per IFRS).
Its operating income was up 44.31% at Rs 254.4 crore versus Rs 176.5 crore. (As Per IFRS)
EBIDTA (earning before interest, depreciation, tax and amortisation) improved on lower costs and better US base business.
Rationalising portfolio and better product mix boosted PAT, the company said.
Launched 5 new products in North America.
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- 10 companies that MF managers love
- 5 stks that were buzzing last week & how to trade them now
- Buy Aban Offshore, target of Rs 2,200: Anand Rathi
- Buy sugar, financials, pharma on declines: Experts
- Sensex ends over 200 pts up led by banks, oil & gas, metals
- Cox and Kings IPO subscribed 6.31 times
- Bharti Airtel reduces roaming charges to 50 paise/min
- In good spirits: Beam Global bets big on India
Source: CNBC-TV18
- Trellisys.net: Cashing in on the social networking craze
Source: Moneycontrol.com
- Aurobindo Pharma sees $2 bn sales in next 3 years
Source: CNBC-TV18
- Now, Daigeo's duty free products are under DRI lens
Source: Moneycontrol.com
- HDFC Standard Life plans IPO in 2010-11
Source: Business Line
- GM India will not cede ground in Chinese alliance
Source: Business Line
- Spices export rises in Oct
Source: Business Line
- Bharat Hotels to invest Rs 2,300 cr in new properties
Source: Business Line
